This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome.
Neurology · 2022
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
Neurology · 2020 · first author
Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
Neurology · 2020
Latest funding
- $50,000
CaPITTAL: Canadian Patient-oriented Immune Tolerance in Transplantation and Autoimmunity to improve Lives
CIHR · 2015 · Principal investigator
7 publications.
Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome.
Mirza AI, Zhu F, Knox N, Forbes JD, Van Domselaar G, Bernstein CN, Graham M, Marrie RA, Hart J, Yeh EA, Arnold DL, Bar-Or A, O'Mahony J, Zhao Y, Hsiao W, Banwell B, Waubant E, Tremlett H
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
Bar-Or A, Calkwood JC, Chognot C, Evershed J, Fox EJ, Herman A, Manfrini M, McNamara J, Robertson DS, Stokmaier D, Wendt JK, Winthrop KL, Traboulsee A
Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
Hauser SL, Kappos L, Arnold DL, Bar-Or A, Brochet B, Naismith RT, Traboulsee A, Wolinsky JS, Belachew S, Koendgen H, Levesque V, Manfrini M, Model F, Hubeaux S, Mehta L, Montalban X
Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis.
Barkhof F, Kappos L, Wolinsky JS, Li DKB, Bar-Or A, Hartung HP, Belachew S, Han J, Julian L, Sauter A, Napieralski J, Koendgen H, Hauser SL
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS, ORATORIO Clinical Investigators
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L, OPERA I and OPERA II Clinical Investigators
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.
Verhey LH, Signori A, Arnold DL, Bar-Or A, Sadovnick AD, Marrie RA, Banwell B, Sormani MP
CaPITTAL: Canadian Patient-oriented Immune Tolerance in Transplantation and Autoimmunity to improve Lives
Principal investigators: Schultz, Kirk R; Tinckam, Kathryn J; Bar-Or, Amit; Keating, Armand; Levings, Megan K
Keywords: Biomarkers; Blood And Marrow Transplantation; Economic Impact Of Health Care; First In Human Clinical Trials; Immune Tolerance; Long Term Outcomes; Multiple Sclerosis; Patient Engagement; Solid Organ Transplantation; Type 1 Diabetes Mellitus
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Brenda Banwell and Amit Bar-Or: 18 shared papers
- Brenda Banwell and Amit Bar-Or: 16 shared papers
- Amit Bar-Or and Amit Bar-Or: 12 shared papers
- Helen Tremlett and Anthony Traboulsee: 9 shared papers
- Helen Tremlett and Helen Tremlett: 7 shared papers
- Amit Bar-Or and Amit Bar-Or: 5 shared papers
- Amit Bar-Or and Anthony Traboulsee: 4 shared papers
- William Hsiao and William Hsiao: 4 shared papers
- Helen Tremlett and William Hsiao: 3 shared papers
- Amit Bar-Or and Amit Bar-Or: 3 shared papers
- Amit Bar-Or and Anthony Traboulsee: 3 shared papers
- Xavier Montalban and Anthony Traboulsee: 3 shared papers
- Amit Bar-Or and Brenda Banwell: 2 shared papers
- Helen Tremlett and Amit Bar-Or: 1 shared paper
- Helen Tremlett and William Hsiao: 1 shared paper
- Helen Tremlett and Gary Van Domselaar: 1 shared paper
- Amit Bar-Or and William Hsiao: 1 shared paper
- Amit Bar-Or and Gary Van Domselaar: 1 shared paper
- Amit Bar-Or and William Hsiao: 1 shared paper
- Amit Bar-Or and Xavier Montalban: 1 shared paper
- Amit Bar-Or and Helen Tremlett: 1 shared paper
- Brenda Banwell and Gary Van Domselaar: 1 shared paper
- Brenda Banwell and Helen Tremlett: 1 shared paper
- Amit Bar-Or and Xavier Montalban: 1 shared paper
- Medicine/Neurology
- Pathology and Laboratory Medicine
- Pediatrics
- Rheumatology
- Molecular Biology and Biochemistry
- Immunology
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Amit Bar-Or
Rheumatology
5 shared papers, latest 2022
Anthony Traboulsee
Medicine/Neurology
4 shared papers, latest 2020
Amit Bar-Or
Faculty
3 shared papers, latest 2022
Brenda Banwell
Faculty
2 shared papers, latest 2022
Gary Van Domselaar
Pathology and Laboratory Medicine
1 shared papers, latest 2022
William Hsiao
Molecular Biology and Biochemistry
1 shared papers, latest 2022
Xavier Montalban
Immunology
1 shared papers, latest 2020
Helen Tremlett
Faculty
1 shared papers, latest 2022
William Hsiao
Pathology and Laboratory Medicine
1 shared papers, latest 2022
Helen Tremlett
Medicine/Neurology
1 shared papers, latest 2022
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.